This is a study for one patient with severe relapsing polychondritis which has been
unresponsive to other more conventional medications including prednisone, methotrexate,
anakinra and TNF inhibitors. Tolerability, and efficacy of the drug, Tocilizumab will be
monitored by clinical assessment and bloodwork.